| Literature DB >> 35855764 |
Nasteho Mohamed Sheikh Omar1, Marian Muse Osman2, Ifrah Adan Hilowle3, Betul Erismis4, Abdirahman Abdikadir Osman5, Osman Abubakar Fiidow6, Ahmed Muhammad Bashir5.
Abstract
Background and Aim: Although postpartum acute kidney injury (PPAKI) is declining in developing countries, it is still a leading cause of maternal and fetal morbidity and mortality. The study aimed to determine the causes, risk factors, and the outcomes of patients with postpartum acute kidney injury managed at Mogadishu Somali Turkey Training and Research Hospital, in Mogadishu, Somalia over a two years period.Entities:
Keywords: Somalia; eclampsia; postpartum AKI; pregnancy-related acute kidney injury
Year: 2022 PMID: 35855764 PMCID: PMC9288188 DOI: 10.2147/IJWH.S372453
Source DB: PubMed Journal: Int J Womens Health ISSN: 1179-1411
Demographics and Clinical Characteristics of the Study Population
| Factors | Frequency/Mean | Died | Survived | P-value | |
|---|---|---|---|---|---|
| <20 | 7(8.9%) | 2(28.6%) | 5(71.4%) | 9.052 | 0.029* |
| 20–30 | 41(52%) | 7(17.1%) | 34(82.9%) | ||
| 31–40 | 29(36.7%) | 0(0.0%) | 29(100.0%) | ||
| >40 | 2(2.5%) | 1(50.0%) | 1(50.0%) | ||
| No Comorbid | 65(82.3%) | 10(15.4%) | 55(84.6%) | 2.466 | 0.651 |
| Hypertension | 8(10.1%) | 0(0.0%) | 8(100.0%) | ||
| Heart Failure | 3(3.8%) | 0(0.0%) | 3(100.0%) | ||
| Diabetes with HTN | 2(2.5%) | 0(0.0%) | 1(100.0%) | ||
| Hypothyroidism | 1(1.3%) | 0(0.0%) | 2(100.0%) | ||
| Eclampsia | 19(24.1%) | 1(5.3%) | 18(94.7%) | 19.350 | 0.152 |
| Sepsis | 4(5.1%) | 2(50%) | 2(50%) | ||
| Uterine rupture | 7(8.9%) | 0(0.0%) | 7(100.0%) | ||
| Placenta previa | 2(2.5%) | 0(0.0%) | 2(100%) | ||
| PPH | 4(5.1%) | 1(25.0%) | 3(75.0%) | ||
| Intrauterine death | 13(16.5%) | 1(7.7%) | 12(92.3%) | ||
| Hemorrhagic Shock | 13(16.5%) | 3(23.1%) | 10(76.9%) | ||
| Placenta abruptio | 7(8.9%) | 0(0.0%) | 7(100.0%) | ||
| Eclampsia and Sepsis | 1(1.3%) | 0(0.0%) | 1(100.0%) | ||
| Uterine rupture Plus Hemorrhagic Shock | 2(2.5%) | 0(0.0%) | 2(100.0%) | ||
| Eclampsia Plus Placenta previa Plus Hemorrhagic Shock | 1(1.3%) | 0 (0.0%) | 1(100.0%) | ||
| Placenta previa Plus Intrauterine death | 1(1.3%) | 0 (0.0%) | 1(100.0%) | ||
| Eclampsia Plus Uterine rupture | 3(3.8%) | 1(33.3%) | 2(66.7%) | ||
| Eclampsia Plus Hemorrhagic Shock | 1(1.3%) | 0(0.0%) | 1(100.0%) | ||
| Sepsis Plus Hemorrhagic Shock | 1(1.3%) | 1(100.0%) | 0(0.0%) | ||
| Anuric | 57(72.15%) | 7(25.9) | 20(74.1) | 2.1 | 0.67 |
| Oliguric | 24(27.84%) | 3(5.8) | 49(94.2) | ||
| 5 days | 7(30.43) | 16(69.56) | 9.5 | 0.009* | |
| 5–10 days | 11.48±11.02 | 2(7.69) | 24(92.30) | ||
| >10 days | 1(3.33) | 29(96.66) | |||
| Not done | 8(10.1%) | 2(25.0%) | 6(75.0%) | 4.424 | 0.219 |
| Normal Abdominal | 17(21.5%) | 4(23.5%) | 13(76.5%) | ||
| Renal Parenchymal Disease | 51(64.6%) | 4(7.8%) | 47(92.2%) | ||
| Unilateral/Bilateral Renal Atrophy | 3(3.8%) | 0(0.0%) | 3(100.0%) | ||
Note: *p values <0.05 are statistically significant.
Abbreviations: IUD, Intrauterine death; USG, ultrasound AKI acute kidney injury; PPH, postpartum hemorrhage.
Laboratory and Clinical Characteristics of the Study Population
| Laboratory and Clinical Characteristics | Frequency/Mean | Died | Survived | P-value | |
|---|---|---|---|---|---|
| Hypoglycemia | 109.67±53.73 | 2(28.6%) | 5(71.4%) | 2.010 | 0.366 |
| Normal | 6(12.5%) | 42(87.5%) | |||
| Hyperglycemia | 2(8.3%) | 22(91.7%) | |||
| 0.461 | 0.395 | ||||
| Normal | 216.91±445.3 | 2(8.7%) | 21(91.3%) | ||
| Abnormal | 8(14.3%) | 48(85.7%) | |||
| 1.950 | 0.145 | ||||
| Normal | 146.29±268.77 | 3(7.5%) | 37(92.5%) | ||
| Abnormal | 7(17.9%) | 32(82.1%) | |||
| 0.611 | 0.575 | ||||
| Normal | 136.37±85.95 | 0(0.0%) | 4(100.0%) | ||
| Abnormal | 10(13.3%) | 65(86.7%) | |||
| 3.387 | 0.184 | ||||
| Low Sodium | 129.56±13.34 | 8(13.6%) | 51(86.4%) | ||
| Normal | 1(5.6%) | 17(94.4%) | |||
| High Sodium | 1(50.0%) | 1(50.0%) | |||
| 3.016 | 0.221 | ||||
| Low Potassium | 10.15±47.40 | 1(14.3%) | 6(85.7%) | ||
| Normal | 4(8.0%) | 46(92.0%) | |||
| High Potassium | 5(22.7%) | 17(77.3%) | |||
| 7.626 | 0.022* | ||||
| Low Uric acid | 9.51±3.08 | 1(100.0%) | 0(0.0%) | ||
| Normal | 2(7.4%) | 25(92.6%) | |||
| High Uric Acid | 7(13.7%) | 44(86.3%) | |||
| 0.774 | 0.679 | ||||
| Low Albumin | 2.86±2.42 | 10(13.5%) | 64(86.5%) | ||
| Normal | 0(0.0%) | 2(100.0%) | |||
| High Albumin | 0(0.0%) | 3(100.0%) | |||
| CPR | 1.113 | 0.372 | |||
| Normal | 76.46±56.79 | 0(0.0%) | 7(100.0%) | ||
| Abnormal | 10(13.9%) | 62(86.1%) | |||
| 8.725 | 0.013* | ||||
| Low Platelet | 4(12.9%) | 27(87.1%) | |||
| Normal | 3(7.1%) | 39(92.9%) | |||
| High platelet | 3(50.0%) | 3(50.0%) | |||
Note: *P-values < 0.05 are statistically significant.
Abbreviations: SD, standard deviation; ALT, Alanine transaminase; AST, Aspartate transaminase; CRP, C-reactive protein.
Figure 1Outcomes of the study population.
Figure 2Classification of anemia according to WHO anemia classification.